Electrophysiological characterization of AGRP neurons showed the presence of SK-mediated tail currents, confirmed by blockade with the highly selective SK channel antagonist, apamin.
We tested if LRRK2 inhibition induced degradation was affected by altering autophagy induction with rapamycin/SMER28 [ 53– 56] or autophagy progression by blockade with the lysosomotropic agent bafilomycin A [ 57], which prevents the acidification of the lysosome and fusion with the autophagosome; or by proteasome inhibition with two distinct proteasome inhibitors, bortezomib and MG132.
This was likely due to the loss of tumor derived JAG1, as indicated by blockade with a JAGGED specific decoy.
Baroreflex responses to TBCO were eliminated by blockade with hexamethonium bromide (10 microg/kg).
[20] In the SHR, increased activity of the RAS is found in the heart [21], [22] and the kidneys [23] while in cultured newborn SHR heart cells, increased uptake of 3H-proline by Ang I and Ang II was abolished by blockade with either an ACE inhibitor or an AT1 receptor antagonist.
Effects of OH transmission were isolated by blocking glutamate and GABA transmission and confirmed as requiring OH receptors by blockade with 10 μM TCS-OX2-29 ("TCS," an OHR2 receptor blocker; Huang et al., 2010, Smart et al., 2001, Xiao et al., 2013) and/or 10 μM SB-334867 ("SB," an OHR1 blocker at this concentration; Smart et al., 2001).
We next investigated whether the enhancing effect of MAGL inhibitors on malonate-induced cell death may be attenuated by the blockade with the PGE2-G antagonist AGN220675 or by inhibiting COX-2 with celecoxib, which would provide further evidence of the role of 2-AG biotransformation in the effects investigated in this study.
Furthermore, the Aβ-dependent actions were demonstrated by their blockade with the Aβ WO2 antibody that recognizes residues 1 to 5 of Aβ (Fig. S1B,C).
The chondroprotective effects of Ucn are abolished by both specific ligand depletion (with an anti-Ucn antibody) and by CRF receptor blockade with the pan-CRFR antagonist α-helical CRH 9-41).
Specifically, these six LCLs were treated with increasing concentrations of E2, followed by blockade of the ER with ICI-182,780 [ 14], still in the presence of 0.01 nM E2.
Large-scale clinical trials have shown that in hypertensive type 2 diabetic patients with microalbuminuria, lowering blood pressure by blockade of the renin-angiotensin system with angiotensin II (Ang II) type 1 (AT1) receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors is more effective in reducing microalbuminuria than any other conventional antihypertensive therapies.
